GenCefe Biotech Verified partner
GenCefe Biotech is a biotechnology company founded in 2020 and headquartered in Wuxi, China, with a U.S. branch established in 2021.
More detail +
The company focuses on molecular biology and synthetic biology technologies, offering a comprehensive portfolio of services including gene synthesis, oligonucleotide synthesis, RNA production, peptide synthesis, and protein expression.
GenCefe integrates high-throughput automation and AI-assisted design platforms to improve efficiency and accuracy in gene synthesis and downstream applications.
Its services support research across cell and gene therapy, vaccine development, molecular diagnostics, and biopharmaceutical development, serving academic institutions, biotech companies, and CROs worldwide.
What makes GenCefe Biotech different
Gene, RNA, peptide, and protein synthesis
GenCefe offers gene synthesis, oligonucleotide synthesis, RNA production, peptide synthesis, and protein expression.
More detail +
This comprehensive portfolio supports molecular and synthetic biology workflows for academic institutions, biotech companies, and CROs worldwide.
Automation and AI-assisted design
GenCefe integrates high-throughput automation and AI-assisted design platforms into its synthesis services.
More detail +
These platforms are used to improve efficiency and accuracy in gene synthesis and downstream applications, supporting demanding synthetic biology projects.
Custom synthesis for therapy and diagnostics
GenCefe provides highly customizable synthesis across gene, RNA, peptide, and protein production.
More detail +
Its services support research in cell and gene therapy, vaccine development, molecular diagnostics, and biopharmaceutical development, backed by technical resources and validation data.
Where they're strong
GenCefe supports advanced molecular biology and synthetic biology workflows through custom synthesis and gene engineering technologies
Product lines & services
GenCefe offers a comprehensive portfolio of synthesis services and reagents designed for molecular biology and drug discovery applications
News & announcements
Choosing an Antigen for Membrane Protein Antibody Discovery
A GPCR, a claudin or an ion channel cannot be expressed as a soluble protein. Seven antigen formats, what each one is for, and...
Read more
CLDN18.2 Cell Line Models: Engineered Antigen Models for Gastric Cancer Target Research
Why CLDN18.2 antibody and CAR-T programmes express the antigen in HEK293, CHO-K1 or K562 rather than gastric cells — and why surface flow cytometry,...
Read more
The C2C12 Muscle Atrophy Model, Target by Target
A reagent-by-reagent map of the C2C12 muscle atrophy model — inducing wasting and measuring FoxO3, Atrogin-1/MuRF1, autophagy, and cachexia cytokines.
Read moreQC, documentation & shipping
Quality control & documentation
GenCefe provides detailed validation and QC processes for synthesis services and reagents
Lead time & shipping
Timelines depend on project complexity and customization level
Request a quote from GenCefe Biotech
Tell us your target and application — a BioHippo scientist will shortlist options and pricing, usually within one business day.